The Depo-Provera lawsuit payout date has not been set yet as of early 2026. No global settlement has been reached, and bellwether trials are still being organized in the MDL proceedings.
Thousands of women who developed meningioma brain tumors after using the Depo-Provera birth control shot are waiting for answers. The litigation is moving through federal court, but payouts are likely still months or even years away.
In this article, you’ll learn where the lawsuit stands right now, what settlement amounts might look like, who qualifies, and what needs to happen before any money changes hands. One striking detail: a 2024 BMJ study found that women who used Depo-Provera for more than three years had a significantly elevated risk of developing meningioma.
If you used Depo-Provera and got diagnosed with a brain tumor, this breakdown covers everything you need to know heading into 2026.
Depo-Provera Lawsuit Payout Date
No official Depo-Provera lawsuit payout date has been announced as of 2026. Settlement talks have not produced a global deal, and the MDL is still in its early-to-mid stages.
For any money to go out, several things need to happen first. Bellwether trials need to conclude. Settlement negotiations need to succeed. A claims process needs to be set up and approved by the court.
Realistically, payouts are unlikely before late 2026 at the earliest, and even that estimate assumes things move quickly. If Pfizer fights aggressively or appeals early verdicts, payouts could slide into 2027 or beyond.
| Milestone | Projected Timing |
|---|---|
| Bellwether trial selections | Mid 2025 to early 2026 |
| First bellwether trials | Mid to late 2026 |
| Settlement negotiations | Late 2026 to 2027 |
| Earliest possible payouts | Late 2026 to 2028 |
Think of it like waiting for a flight that keeps getting delayed. The plane is at the gate, but the crew hasn’t boarded yet. That’s roughly where this litigation stands right now.
The best thing claimants can do is file their claim, stay in contact with their attorney, and keep their medical records organized while the legal process plays out.
Depo-Provera Lawsuit Settlements
Depo-Provera lawsuit settlements have not been finalized as of 2026. No individual settlements or global settlement fund has been announced publicly.
That’s not unusual for mass tort cases at this stage. Settlement talks typically don’t gain real momentum until after bellwether trials produce verdicts. Those verdicts give both sides a sense of what juries think the cases are worth.
In similar pharmaceutical mass torts, settlements have followed one of two paths. Either Pfizer negotiates a lump-sum global settlement that covers all claimants, or individual cases settle one by one based on injury severity.
- Global settlement: A single fund covering all eligible claimants, distributed through a claims administrator
- Individual settlements: Case-by-case negotiations, often resulting in higher payouts for severe injuries
- Hybrid approach: A global fund with separate tracks for different injury tiers
Right now, plaintiff attorneys are building the strongest possible cases to pressure Pfizer toward the negotiation table. The stronger the trial results, the bigger the settlement pot.
For context, the Bayer Roundup litigation resulted in an $11 billion global settlement after several plaintiff verdicts. The Depo-Provera case won’t hit those numbers, but the comparison shows how trial outcomes drive settlements.
Depo-Provera Settlement Amounts
Depo-Provera settlement amounts are projected to range between $100,000 and $1.5 million or more per claimant, depending on injury severity and individual circumstances.
These numbers come from legal analysts comparing the Depo-Provera litigation to similar pharmaceutical brain tumor cases. No official figures have been confirmed because no settlements have been reached yet.
| Injury Severity | Estimated Settlement Range |
|---|---|
| Meningioma (no surgery needed) | $100,000 to $300,000 |
| Meningioma (surgery required) | $300,000 to $750,000 |
| Multiple meningiomas or recurrence | $500,000 to $1,000,000 |
| Severe complications, disability, or death | $750,000 to $1,500,000+ |
Several factors will influence where each case falls on that spectrum:
- Duration of Depo-Provera use (longer use strengthens the claim)
- Tumor size and location in the brain
- Whether surgery was required and how invasive it was
- Ongoing medical costs and lost wages
- Age at diagnosis and impact on quality of life
The women with the strongest cases will have clear medical records showing years of Depo-Provera use followed by a meningioma diagnosis. Those cases sit at the top of the payout range.
Key Takeaway: No Depo-Provera lawsuit payout date has been set, settlements haven’t been finalized, but estimated payouts range from $100,000 to over $1.5 million based on injury severity.
Depo-Provera Payout Per Person
The Depo-Provera payout per person will depend entirely on individual case details. There’s no flat dollar amount that every claimant will receive.
Mass tort cases don’t work like class action settlements where everyone gets the same check. Each person’s payout is calculated based on their specific injuries, medical expenses, and the strength of their evidence.
A woman who used Depo-Provera for ten years and needed two brain surgeries will receive significantly more than someone who used it for one year and had a small, asymptomatic tumor discovered incidentally.
Here’s what drives the per-person number:
- Medical expenses already incurred (surgery, imaging, treatment)
- Future medical costs (monitoring, follow-up MRIs, potential repeat surgery)
- Lost income from missed work or disability
- Pain and suffering based on the severity and impact of the tumor
- Punitive damages if a jury finds Pfizer acted with reckless disregard
In some pharmaceutical mass torts, per-person payouts have ranged from as low as $5,000 (for minor injuries in class actions) to several million dollars for catastrophic harm. The Depo-Provera cases involving brain surgery and lasting neurological effects will land on the higher end.
Your attorney’s ability to document and present your damages plays a huge role in the final number.
When Will the Depo-Provera Lawsuit Pay Out
The Depo-Provera lawsuit will most likely not pay out before late 2026 or 2027. The litigation needs to pass through several more stages before money reaches claimants.
Here’s the honest truth: mass tort cases take time. The tobacco litigation lasted over a decade. The opioid cases dragged on for years. Depo-Provera is moving faster than some, but it’s still not close to the finish line.
Before anyone gets paid, these steps must happen:
- Bellwether trials must be completed (first ones expected mid to late 2026)
- Settlement negotiations must produce an agreement
- Court approval of any global settlement
- Claims administration setup and claimant verification
- Distribution of funds to verified claimants
Even after a settlement is announced, it typically takes 6 to 18 months for checks to actually arrive. Claims administrators need time to verify eligibility, process paperwork, and calculate individual amounts.
If you’ve already filed your claim, patience is the name of the game. If you haven’t filed yet, doing it now ensures you’re in line when the process eventually moves forward.
Depo-Provera Lawsuit Update 2026
The Depo-Provera lawsuit update for 2026 centers on the continued growth of the MDL and preparation for bellwether trials. As of early 2026, the litigation is in active discovery and case selection phases.
Key developments in the case:
- MDL 3127 continues in the U.S. District Court for the Western District of North Carolina under Judge Robert J. Conrad Jr.
- The number of cases filed in the MDL has grown significantly, with new plaintiffs joining regularly
- Discovery is ongoing, with Pfizer producing internal documents about what it knew regarding meningioma risks
- Bellwether cases are being selected to represent the broader pool of claims
| 2026 Status Item | Current Detail |
|---|---|
| Presiding Judge | Judge Robert J. Conrad Jr. |
| Court | W.D. North Carolina |
| MDL Number | 3127 |
| Phase | Discovery and bellwether preparation |
| Estimated case count | Hundreds and growing |
The pace of the case in 2026 will likely determine whether settlements happen in late 2026 or get pushed to 2027. Plaintiffs’ attorneys are working to keep the pressure on Pfizer by showing strong scientific evidence and compelling individual stories.
This is the year when the real groundwork gets laid. What happens in 2026 shapes everything that follows.
Key Takeaway: The earliest realistic payout window is late 2026 to 2027, with bellwether trial preparation and discovery dominating the 2026 litigation calendar.
Depo-Provera Meningioma Lawsuit
The Depo-Provera meningioma lawsuit involves thousands of women who developed meningioma brain tumors after receiving the Depo-Provera contraceptive injection. The lawsuits allege that Pfizer knew about the risk and failed to warn patients.
Meningioma is a tumor that grows in the meninges, the protective membranes surrounding the brain and spinal cord. While most meningiomas are technically benign, they can cause serious symptoms and often require surgery.
The scientific connection between Depo-Provera and meningioma is built on multiple studies:
- A 2024 BMJ study found a strong association between prolonged progestogen use and meningioma development
- The active ingredient medroxyprogesterone acetate is a synthetic progestogen that meningioma tumors have receptors for
- Earlier research from France led to restrictions on a similar progestogen medication (cyproterone acetate) due to meningioma risk
The plaintiffs argue that Pfizer had access to this scientific data for years. They claim the company chose profits over patient safety by not updating the drug’s warning label.
Symptoms that led many women to discover their meningiomas include:
- Chronic headaches
- Vision changes or loss
- Seizures
- Memory problems
- Weakness in limbs
For some women, the tumors were found incidentally during imaging for other conditions. Regardless of how the tumor was discovered, the connection to Depo-Provera use is what drives the legal claim.
Depo-Provera Brain Tumor Lawsuit
The Depo-Provera brain tumor lawsuit is specifically focused on meningioma, a type of brain tumor linked to the synthetic progestogen in the contraceptive shot. This isn’t about headaches or minor side effects. It’s about tumors growing inside the skull.
Brain tumors change lives permanently. Even when a meningioma is classified as “benign,” the treatment is anything but simple. Many women have undergone craniotomies, which involve cutting through the skull to remove the tumor.
The financial toll is staggering:
| Cost Category | Typical Range |
|---|---|
| Brain surgery (craniotomy) | $50,000 to $200,000+ |
| MRI imaging (per scan) | $1,000 to $5,000 |
| Post-surgical rehabilitation | $10,000 to $50,000 |
| Lost wages (6 to 12 months) | $30,000 to $80,000 |
| Ongoing monitoring (annual MRIs) | $2,000 to $5,000 per year |
Beyond money, many women report lasting effects. Cognitive changes, personality shifts, chronic fatigue, and anxiety about tumor recurrence are common.
The brain tumor lawsuit seeks to compensate women for all of these losses. Medical bills are just the starting point. Pain, suffering, lost quality of life, and emotional distress are all part of the damages calculation.
Every case is built around the same core question: did Pfizer know that Depo-Provera could cause brain tumors, and did it fail to warn the women taking it?
Depo-Provera Lawsuit Eligibility
Depo-Provera lawsuit eligibility requires two main things: documented use of the Depo-Provera injection and a subsequent diagnosis of meningioma. If you have both, you likely have a valid claim.
The eligibility criteria are straightforward, but the details matter. Here’s what attorneys typically look for:
- Received at least one Depo-Provera or Depo-SubQ Provera 104 injection
- Diagnosed with a meningioma (intracranial) after starting the injections
- Medical records that document both the drug use and the diagnosis
| Eligibility Factor | What’s Required |
|---|---|
| Drug used | Depo-Provera or Depo-SubQ Provera 104 |
| Minimum use | At least one injection (longer use strengthens claim) |
| Diagnosis | Meningioma brain tumor confirmed by imaging or pathology |
| Timing | Diagnosis after beginning Depo-Provera use |
| Documentation | Medical records showing both drug use and tumor diagnosis |
You don’t need to prove that Depo-Provera definitely caused your tumor. Your attorney and the scientific evidence presented at trial handle that part. You just need to show that you used the drug and developed the condition.
Women who used Depo-Provera for longer periods, especially three years or more, generally have the strongest cases based on the dose-response relationship identified in the BMJ study.
Key Takeaway: You may qualify for the Depo-Provera lawsuit if you received the injection and were later diagnosed with a meningioma brain tumor, with longer use strengthening your case.
Who Qualifies for the Depo-Provera Lawsuit
Anyone who received Depo-Provera injections and was diagnosed with meningioma may qualify for this lawsuit. There is no age restriction, and the qualifying period spans several decades of the drug’s use.
Some common questions women ask:
“I only had a few injections. Do I qualify?”
Yes, potentially. Even short-term use may be sufficient, though longer use creates a stronger link to the tumor.
“My meningioma was small and didn’t require surgery. Do I still qualify?”
Yes. You don’t need to have had surgery. A confirmed meningioma diagnosis is enough to begin the process.
“I used Depo-Provera 15 years ago. Is it too late?”
Not necessarily. Meningiomas are slow-growing tumors. Many women don’t discover them until years after starting the injections. The statute of limitations typically starts from the date of diagnosis, not the date of drug use.
Who does NOT qualify:
- Women who used other forms of birth control but never received Depo-Provera injections
- Women who used Depo-Provera but were never diagnosed with meningioma
- Claimants with tumors in locations not associated with progestogen exposure
If you’re unsure whether your situation fits, gathering your medical records is the best first step. Pharmacy records, injection logs from your doctor’s office, and diagnostic imaging reports are the documents that matter most.
How to File a Depo-Provera Lawsuit
Filing a Depo-Provera lawsuit involves contacting a qualified mass tort attorney, gathering your medical records, and having your case evaluated for inclusion in the MDL or a state court filing.
Here’s the step-by-step process:
- Contact a mass tort law firm that handles pharmaceutical litigation
- Provide your basic information about Depo-Provera use and meningioma diagnosis
- Sign a retainer agreement if the firm accepts your case
- Gather medical records (the firm usually helps with this)
- Your case gets filed in the MDL (MDL 3127) or in state court
Most Depo-Provera attorneys work on a contingency fee basis. That means you pay nothing upfront. The attorney gets paid only if you receive a settlement or verdict.
| Filing Detail | What to Know |
|---|---|
| Cost to file | $0 upfront (contingency fee) |
| Attorney fee | Typically 33% to 40% of your settlement |
| Where cases are filed | MDL 3127, W.D. North Carolina or state courts |
| Time to file | Varies; don’t wait, statutes of limitations apply |
| What you need | Medical records, pharmacy records, diagnosis documentation |
The sooner you file, the better your position. Early filers often get included in the first waves of settlement distribution. Waiting too long risks running into statute of limitations issues.
Filing doesn’t mean you go to court. The vast majority of mass tort cases settle before any individual claimant sits in a courtroom.
Depo-Provera Lawsuit Evidence Needed
The evidence needed for a Depo-Provera lawsuit comes down to proving two things: that you used the drug and that you developed a meningioma. Strong documentation makes a strong case.
Here’s what your attorney will want to collect:
Medical Records:
- Records from the doctor or clinic that administered your Depo-Provera injections
- Dates, dosages, and frequency of injections
- Any notes from your provider about side effects or concerns
Diagnostic Evidence:
- MRI or CT scan reports showing the meningioma
- Pathology reports if the tumor was biopsied or removed
- Surgical records if you had a craniotomy or other procedure
Financial Documentation:
- Medical bills related to the tumor diagnosis and treatment
- Records of lost wages or reduced work capacity
- Receipts for travel, childcare, or other costs tied to treatment
Personal Impact Evidence:
- A journal or written account of how the tumor affected your daily life
- Statements from family members about changes they observed
- Documentation of mental health treatment related to the diagnosis
| Evidence Type | Why It Matters |
|---|---|
| Injection records | Proves you used Depo-Provera |
| MRI/CT reports | Confirms meningioma diagnosis |
| Surgery records | Shows severity of injury |
| Medical bills | Quantifies financial damages |
| Personal statements | Supports pain and suffering claims |
If you can’t find your old injection records, don’t panic. Your attorney can often obtain pharmacy records, insurance claims data, and medical office records through subpoenas and formal requests.
Key Takeaway: Build your case with injection records, diagnostic imaging, surgical records, medical bills, and personal impact documentation to maximize your potential payout.
Depo-Provera MDL Status
The Depo-Provera MDL (Multidistrict Litigation No. 3127) is active and growing in the U.S. District Court for the Western District of North Carolina. Judge Robert J. Conrad Jr. is overseeing all federal cases.
MDL stands for multidistrict litigation. It’s a process that consolidates similar federal lawsuits into one court for pretrial proceedings. This makes the process more efficient than having hundreds of separate cases in different courtrooms.
The MDL was established after the U.S. Judicial Panel on Multidistrict Litigation (JPML) agreed that the cases shared common factual questions. All federal Depo-Provera meningioma cases have been transferred to this single court.
| MDL Detail | Information |
|---|---|
| MDL Number | 3127 |
| Court | U.S. District Court, W.D. North Carolina |
| Judge | Robert J. Conrad Jr. |
| Current phase | Discovery and bellwether preparation |
| Case volume | Hundreds of cases, growing monthly |
Key things happening in the MDL right now:
- Discovery: Both sides are exchanging documents. Pfizer is turning over internal communications, safety data, and marketing materials.
- Expert witnesses: Plaintiffs are retaining medical experts to testify about the medroxyprogesterone-meningioma link.
- Bellwether selection: The court is identifying representative cases to try first.
Not all Depo-Provera cases are in the MDL. Some have been filed in state courts. But the MDL outcomes will heavily influence all cases, including state filings, because they set expectations for settlement values.
Depo-Provera Bellwether Trials
Depo-Provera bellwether trials are expected to begin in mid to late 2026. These are test cases selected to represent the larger pool of claims and gauge how juries respond to the evidence.
Bellwether trials serve as a reality check for both sides. If plaintiffs win big verdicts, Pfizer has strong motivation to settle. If Pfizer wins, it gains leverage to push for lower settlement amounts or fight the cases individually.
How bellwether selection works:
- The court and attorneys from both sides select a small group of cases (typically 4 to 10)
- These cases represent a range of injury severities, drug use durations, and demographics
- Each case goes to trial individually, with full proceedings
- The outcomes inform settlement negotiations but don’t legally bind other cases
| Bellwether Element | Detail |
|---|---|
| Number of cases selected | Typically 4 to 10 |
| Expected start | Mid to late 2026 |
| Purpose | Test evidence and jury reactions |
| Impact | Drives settlement negotiations |
| Binding on other cases? | No, but highly influential |
In the Roundup litigation, early bellwether verdicts of $289 million, $80 million, and $2 billion sent Bayer rushing to the settlement table. Plaintiff attorneys in the Depo-Provera case are hoping for a similar dynamic.
The selection of bellwether cases is strategic. Plaintiffs want cases with long Depo-Provera use, severe tumors, and sympathetic stories. Pfizer wants cases with weaker evidence or confounding medical histories.
Depo-Provera Lawsuit Timeline
The Depo-Provera lawsuit timeline stretches from the initial scientific findings through MDL formation and into the trial and settlement phases expected throughout 2026 and beyond.
Here’s a clear chronological breakdown:
| Year | Event |
|---|---|
| 2004 | FDA adds black box warning about bone loss but not meningioma |
| 2020 to 2023 | Growing research links progestogens to meningioma risk |
| March 2024 | Major BMJ study published showing elevated meningioma risk with prolonged progestogen use |
| Mid 2024 | First Depo-Provera meningioma lawsuits filed |
| Late 2024 | JPML consolidates federal cases into MDL 3127 |
| Early 2025 | MDL assigned to Judge Conrad in W.D. North Carolina |
| 2025 | Discovery phase begins; case count grows rapidly |
| Early to mid 2026 | Bellwether case selection and preparation |
| Mid to late 2026 | First bellwether trials expected |
| Late 2026 to 2027 | Settlement negotiations anticipated |
| 2027 to 2028 | Earliest realistic payout window |
The timeline could shift in either direction. If Pfizer decides to settle early to avoid bad press from trial verdicts, things speed up. If Pfizer fights every step and files appeals, the timeline stretches.
Mass tort timelines are unpredictable by nature. The Vioxx litigation took about four years from first filing to settlement. The opioid cases took over five years. Depo-Provera could fall somewhere in that range.
Key Takeaway: The Depo-Provera lawsuit timeline points to bellwether trials in 2026, with realistic settlement talks in late 2026 to 2027 and payouts following 6 to 18 months after any deal.
Depo-Provera Settlement Payout Process
The Depo-Provera settlement payout process will follow a structured series of steps once a settlement is reached. Understanding this process helps set realistic expectations about timing.
Here’s how it typically works in mass tort cases:
- Settlement agreement reached between plaintiffs’ leadership committee and Pfizer
- Court reviews and approves the settlement terms
- Claims administrator appointed to manage distribution
- Notice sent to claimants explaining how to submit their claim
- Claimants submit documentation (medical records, proof of use, damages evidence)
- Claims reviewed and scored based on injury severity tiers
- Payout amounts calculated for each individual claimant
- Checks or wire transfers distributed
| Process Step | Estimated Duration |
|---|---|
| Settlement to court approval | 2 to 4 months |
| Claims administrator setup | 1 to 3 months |
| Claims submission window | 3 to 6 months |
| Review and scoring | 2 to 6 months |
| Payout distribution | 1 to 3 months |
| Total after settlement | 9 to 22 months |
This means that even after a settlement is announced, it could take a year or more before you see a check. That’s the part most people don’t realize. The settlement announcement is the beginning of the payout process, not the end.
Your attorney handles most of this paperwork on your behalf. Your job is to provide documentation when requested and respond promptly to any communications from the claims administrator.
Depo-Provera Lawsuit Average Settlement
The Depo-Provera lawsuit average settlement is projected to fall between $250,000 and $500,000 based on comparisons to similar pharmaceutical mass torts. This is a mid-range estimate covering all injury levels.
That average accounts for cases ranging from small, untreated meningiomas to severe cases requiring multiple surgeries. When you blend the full spectrum, you land in that middle range.
Here’s how Depo-Provera compares to other pharmaceutical brain tumor or serious injury mass torts:
| Mass Tort | Average Settlement Per Claimant |
|---|---|
| Roundup (cancer) | $150,000 to $175,000 (global settlement average) |
| Transvaginal mesh | $60,000 to $100,000 |
| Talcum powder (ovarian cancer) | $100,000 to $1,000,000+ |
| Depo-Provera (projected) | $250,000 to $500,000 |
A few important notes about averages:
- Averages get pulled up by very high payouts for severe cases
- Averages get pulled down by large numbers of lower-tier claims
- Your individual settlement could be well above or below the average
- The average will only become clear after the settlement structure is finalized
Don’t fixate on the average number. What matters is your specific case: how long you used Depo-Provera, how severe your meningioma was, what treatment you needed, and how well your damages are documented.
Legal analysts will refine these projections once bellwether trial results come in. Those verdicts give the clearest signal yet of what juries think these cases are worth.
Depo-Provera and Pfizer Lawsuit
The Depo-Provera Pfizer lawsuit targets Pfizer Inc. as the manufacturer responsible for the drug’s safety warnings and marketing. Pfizer inherited this liability when it acquired Pharmacia & Upjohn, the company that originally developed and marketed Depo-Provera.
Pfizer is one of the largest pharmaceutical companies in the world, with annual revenues exceeding $50 billion. The company has the resources to fight this litigation for years if it chooses to.
The core allegations against Pfizer include:
- Failure to warn: Pfizer knew or should have known about the meningioma risk but didn’t add it to the drug’s warning label
- Negligent marketing: The drug was promoted without adequate disclosure of brain tumor risks
- Design defect: The formulation of medroxyprogesterone acetate poses unreasonable risks
- Fraud by concealment: Pfizer allegedly suppressed or downplayed safety data
| Allegation | Key Argument |
|---|---|
| Failure to warn | Label lacked meningioma risk information |
| Negligent marketing | Drug promoted as safe without full risk disclosure |
| Design defect | Active ingredient creates unreasonable brain tumor risk |
| Concealment | Internal data about meningioma link not shared publicly |
Pfizer’s likely defense strategy will focus on challenging the causal link between medroxyprogesterone acetate and meningioma. The company may argue that other risk factors, such as genetics, obesity, or hormone exposure from other sources, explain the tumors.
The company has a track record of settling large mass torts. Pfizer settled the Protonix litigation, the Zoloft birth defects cases, and other drug lawsuits. Whether it settles the Depo-Provera cases depends heavily on bellwether trial results.
Key Takeaway: Pfizer faces serious allegations of concealing meningioma risks, and its decision to settle or fight will be shaped by bellwether trial outcomes expected in 2026.
Frequently Asked Questions
When is the Depo-Provera lawsuit payout date in 2026?
No specific payout date has been set for 2026.
Bellwether trials are expected mid to late 2026, with settlements and payouts likely following in late 2026 to 2028.
The timeline depends on trial results and Pfizer’s willingness to negotiate.
How much money will I get from a Depo-Provera settlement?
Estimated payouts range from $100,000 to $1.5 million depending on injury severity.
Cases involving brain surgery and lasting disability fall at the top of that range.
The average settlement is projected between $250,000 and $500,000.
Do I qualify for the Depo-Provera meningioma lawsuit?
You may qualify if you received Depo-Provera injections and were diagnosed with a meningioma.
Both short-term and long-term users can file, though longer use strengthens the case.
Medical records documenting both drug use and the tumor diagnosis are required.
Has Pfizer settled any Depo-Provera brain tumor lawsuits?
No, Pfizer has not settled any Depo-Provera meningioma cases as of early 2026.
The MDL is still in discovery and bellwether preparation phases.
Settlement talks are expected to begin after the first trial verdicts come in.
How long will the Depo-Provera lawsuit take to resolve?
Most mass tort cases of this size take 3 to 7 years from first filing to final payouts.
The Depo-Provera MDL was formed in late 2024, putting full resolution somewhere between 2027 and 2031.
Early settlements for strong cases could happen sooner, especially after favorable bellwether verdicts.
This lawsuit is far from over, but it’s moving. Bellwether trials expected in 2026 will shape everything that comes next, from settlement amounts to payout timing.
If you used Depo-Provera and have a meningioma diagnosis, gather your records now. File your claim before statute of limitations deadlines close the door.
Stay informed as the MDL progresses. The women in this case deserve answers, and 2026 is the year those answers start to take shape.
